Syra Operating Cycle from 2010 to 2025
| SYRA Stock | USD 0.10 0.01 9.09% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 31.1324608 | Current Value 29.58 | Quarterly Volatility 15.8445953 |
Check Syra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.1 K, Other Operating Expenses of 6.4 M or Total Operating Expenses of 2.9 M, as well as many indicators such as Price To Sales Ratio of 0.36, Dividend Yield of 0.0 or PTB Ratio of 1.09. Syra financial statements analysis is a perfect complement when working with Syra Health Valuation or Volatility modules.
Syra | Operating Cycle | Build AI portfolio with Syra Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Syra Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Syra Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Syra Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Syra Health Corp Stock:Check out the analysis of Syra Health Correlation against competitors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syra Health. If investors know Syra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Syra Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Revenue Per Share | Quarterly Revenue Growth (0.25) | Return On Assets | Return On Equity |
The market value of Syra Health Corp is measured differently than its book value, which is the value of Syra that is recorded on the company's balance sheet. Investors also form their own opinion of Syra Health's value that differs from its market value or its book value, called intrinsic value, which is Syra Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Syra Health's market value can be influenced by many factors that don't directly affect Syra Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Syra Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Syra Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Syra Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.